Axogen (AXGN)

Executive Summary

Axogen is a leading medical technology company focused on peripheral nerve repair and regeneration. With a portfolio of FDA-cleared products, including Avance Nerve Graft, Axoguard Nerve Connector, and Axoguard Nerve Protector, the company addresses the significant unmet need in surgical nerve reconstruction. Axogen's solutions enable surgeons to restore function and sensation in patients suffering from nerve damage, positioning the company as a key player in the nerve repair market. The company has a strong commercial presence in the United States and is expanding internationally. Axogen's pipeline includes ongoing clinical trials to support label expansions and new product indications, leveraging its proprietary processing technology for nerve allografts.

Upcoming Catalysts (preview)

• Q3 2026Q3 2026 Earnings Report – Revenue Growth Update95% success
• TBDFDA 510(k) Clearance for Expanded Indication of Avance Nerve Graft60% success
• Q4 2026Initiation of Pivotal Trial for New Nerve Repair Product50% success